RB1 and lung cancer: The identity of other epigenetic factors that become dysregulated in EGFR/TP53/RB1 mutant lung cancers and their effects on mutant EGFR lung cancer lineage plasticity and therapeutic resistance is an area of active research that may yield additional therapeutic targets.